2-((4-((3,4-Dichlorophenethyl)amino)-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-N-ethyl-2,3-dihydro-1H-indene-2-carboxamide

ID: ALA3298197

Chembl Id: CHEMBL3298197

PubChem CID: 90645233

Max Phase: Preclinical

Molecular Formula: C36H35Cl2F3N8O2

Molecular Weight: 739.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)C1(Nc2nc(NCCc3ccc(Cl)c(Cl)c3)nc(N3CC4CC3CN4C(=O)c3cccc(C(F)(F)F)c3)n2)Cc2ccccc2C1

Standard InChI:  InChI=1S/C36H35Cl2F3N8O2/c1-2-42-31(51)35(17-23-6-3-4-7-24(23)18-35)47-33-44-32(43-13-12-21-10-11-28(37)29(38)14-21)45-34(46-33)49-20-26-16-27(49)19-48(26)30(50)22-8-5-9-25(15-22)36(39,40)41/h3-11,14-15,26-27H,2,12-13,16-20H2,1H3,(H,42,51)(H2,43,44,45,46,47)

Standard InChI Key:  NOTIBQBOROOYKJ-UHFFFAOYSA-N

Associated Targets(Human)

ITGAL Tclin Leukocyte adhesion glycoprotein LFA-1 alpha (170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 739.63Molecular Weight (Monoisotopic): 738.2212AlogP: 6.04#Rotatable Bonds: 10
Polar Surface Area: 115.38Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.04CX Basic pKa: 11.15CX LogP: 7.57CX LogD: 6.29
Aromatic Rings: 4Heavy Atoms: 51QED Weighted: 0.18Np Likeness Score: -1.10

References

1. Kollmann CS, Bai X, Tsai CH, Yang H, Lind KE, Skinner SR, Zhu Z, Israel DI, Cuozzo JW, Morgan BA, Yuki K, Xie C, Springer TA, Shimaoka M, Evindar G..  (2014)  Application of encoded library technology (ELT) to a protein-protein interaction target: discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists.,  22  (7): [PMID:24593905] [10.1016/j.bmc.2014.01.050]

Source